The START Center for Cancer Research
Brian Slack is an accomplished professional in the field of business development and sales, currently serving as Vice President of Key Accounts - Phase 1 at The START Center for Cancer Research since March 2025. Prior to this role, Brian held various positions at WCG from November 2017 to March 2025, including Vice President, Senior Director, and Director of Business Development. Experience also includes a tenure at Progenity, Inc., where Brian progressed from Senior Account Sales Representative to Account Sales Representative between August 2015 and November 2017, and earlier work as a Medical Device Specialist at Cardinal Health from August 2013 to June 2015. Brian earned a Bachelor of Arts & Sciences in Communications, with a focus on Mass Communications, from Miami University in 2013.
This person is not in any teams
This person is not in any offices
The START Center for Cancer Research
1 followers
Deeply rooted in community oncology centers globally, the START Center for Cancer Research provides patients with access to specialized Phase 1 clinical trials for novel anti-cancer agents. With research sites in the United States and in Spain, Portugal, and Ireland, START’s clinical trial sites have conducted more than 1,300 early phase clinical trials, including for 43 therapies that have gained FDA/EMA approval. Founded in Texas in 2007, START today boasts 25 Principal Investigators (PIs) across its worldwide clinical trial sites. With over 100,000+ square feet of world-class research facilities, START offers patients comprehensive treatment plans that include multi-specialty services, genetic profiling of tumors, targeted therapies, state-of-the-art treatment technology, and advanced access to clinical research options. START is committed to accelerating passage from trials to treatments, and to delivering hope to patients, families, and physicians around the world.